Literature DB >> 35028886

Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Matteo Renzulli1, Nicolò Brandi2, Giulia Argalia3, Stefano Brocchi2, Andrea Farolfi3, Stefano Fanti3, Rita Golfieri2.   

Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide and one of the most common causes of death among patients with cirrhosis, developing in 1-8% of them every year, regardless of their cirrhotic stage. The radiological features of HCC are almost always sufficient for reaching the diagnosis; thus, histological confirmation is rarely needed. However, the study of cirrhotic livers remains a challenge for radiologists due to the developing of fibrous and regenerative tissue that cause the distortion of normal liver parenchyma, changing the typical appearances of benign lesions and pseudolesions, which therefore may be misinterpreted as malignancies. In addition, a correct distinction between pseudolesions and malignancy is crucial to allow appropriate targeted therapy and avoid treatment delays.The present review encompasses technical pitfalls and describes focal benign lesions and pseudolesions that may be misinterpreted as HCC in cirrhotic livers, providing the imaging features of regenerative nodules, large regenerative nodules, siderotic nodules, hepatic hemangiomas (including rapidly filling and sclerosed hemangiomas), segmental hyperplasia, arterioportal shunts, focal confluent fibrosis and focal fatty changes. Lastly, the present review explores the most promising new imaging techniques that are emerging and that could help radiologists differentiate benign lesions and pseudolesions from overt HCC.
© 2022. Italian Society of Medical Radiology.

Entities:  

Keywords:  Cirrhosis; Diagnosis; Hepatocellular carcinoma; Magnetic resonance imaging; Neoplasms

Mesh:

Year:  2022        PMID: 35028886     DOI: 10.1007/s11547-022-01449-w

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  119 in total

Review 1.  Pitfalls in Liver Imaging.

Authors:  Valérie Vilgrain; Matthieu Lagadec; Maxime Ronot
Journal:  Radiology       Date:  2016-01       Impact factor: 11.105

Review 2.  Diagnostic histopathology of hepatocellular carcinoma: A case-based review.

Authors:  Rashmi M Agni
Journal:  Semin Diagn Pathol       Date:  2016-12-21       Impact factor: 3.464

3.  Application of the ESR iGuide clinical decision support system to the imaging pathway of patients with hepatocellular carcinoma and cholangiocarcinoma: preliminary findings.

Authors:  Michela Gabelloni; Matteo Di Nasso; Riccardo Morganti; Lorenzo Faggioni; Gianluca Masi; Alfredo Falcone; Emanuele Neri
Journal:  Radiol Med       Date:  2020-02-04       Impact factor: 3.469

4.  Characterization of liver nodules in patients with chronic liver disease by MRI: performance of the Liver Imaging Reporting and Data System (LI-RADS v.2018) scale and its comparison with the Likert scale.

Authors:  Andrea Esposito; Valentina Buscarino; Dario Raciti; Elena Casiraghi; Matteo Manini; Pietro Biondetti; Laura Forzenigo
Journal:  Radiol Med       Date:  2019-10-05       Impact factor: 3.469

5.  Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma.

Authors:  Alessandro Cucchetti; Franco Trevisani; Alberta Cappelli; Cristina Mosconi; Matteo Renzulli; Antonio Daniele Pinna; Rita Golfieri
Journal:  Dig Liver Dis       Date:  2016-05-20       Impact factor: 4.088

Review 6.  Epidemiology of hepatocellular carcinoma: consider the population.

Authors:  Sahil Mittal; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

7.  Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.

Authors:  Francesco Tovoli; Matteo Renzulli; Giulia Negrini; Stefano Brocchi; Alessia Ferrarini; Andrea Andreone; Francesca Benevento; Rita Golfieri; Antonio Maria Morselli-Labate; Marianna Mastroroberto; Radu Ion Badea; Fabio Piscaglia
Journal:  Eur Radiol       Date:  2018-04-09       Impact factor: 5.315

8.  Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.

Authors:  George N Ioannou; Meaghan F Splan; Noel S Weiss; George B McDonald; Laura Beretta; Sum P Lee
Journal:  Clin Gastroenterol Hepatol       Date:  2007-05-16       Impact factor: 11.382

9.  Histology of Hepatocellular Carcinoma: Association with Clinical Features, Radiological Findings, and Locoregional Therapy Outcomes.

Authors:  Benjamin V Park; Ron C Gaba; Yu-Hui Huang; Yi-Fan Chen; Grace Guzman; R Peter Lokken
Journal:  J Clin Imaging Sci       Date:  2019-11-18

Review 10.  Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.

Authors:  Maria Guarino; Anna Sessa; Valentina Cossiga; Federica Morando; Nicola Caporaso; Filomena Morisco
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

View more
  2 in total

1.  HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis.

Authors:  Mei-Ling Dong; Xu Wen; Xin He; Ji-Hua Ren; Hai-Bo Yu; Yi-Ping Qin; Zhen Yang; Min-Li Yang; Chong-Yang Zhou; Hui Zhang; Sheng-Tao Cheng; Juan Chen
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

2.  The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma.

Authors:  Lun Lu; ChenCai Zhang; Xian Yu; Ling Zhang; YaYuan Feng; YuXian Wu; JinJu Xia; Xue Chen; RuiPing Zhang; Juan Zhang; Ningyang Jia; SiSi Zhang
Journal:  J Oncol       Date:  2022-09-15       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.